Forecasting News and Research

RSS

Business leaders should continue to monitor H1N1 risk management to alleviate major impact on costs and revenues

The swine flu pandemic may be off the media’s radar screen, but business executives can ill afford to rest easy. Experts from the National Center for Critical Incident Analysis (NCCIA), who have studied how to respond to pandemics and bioterrorism attacks, warn that executives need to continue to monitor and manage unknown risk factors that might cause the flu to have a major impact upon costs and revenues.

8 Jan 2010

CEI releases new diabetes market forecast study

Since 2008, Cutting Edge Information has developed forecasting data for the diabetes treatment market. The new report -- "Diabetes Market Forecast to 2015" -- provides a deep analysis of the relevant clinical, commercial, and market trends affecting diabetes therapeutics today and their impact leading into the next decade. In addition to detailed drug, class, and company profiles, the study includes primary research findings generated from survey data and interviews with leading physicians and marketing executives.

7 Jan 2010

Sg2: Demand for outpatient services to increase by nearly 22% over the next decade

Between now and 2019, the health care industry will see demand for outpatient services increase by nearly 22% while demand for inpatient services remains flat, according to Sg2, a future-focused health care information systems company. This will require hospitals to shift focus beyond the acute care center and look to services that span the care continuum.

6 Jan 2010

Summa Health System to implement Agilysys' software solution suite

Agilysys, Inc., a leading provider of innovative information technology and hospitality software solutions, announced today that Summa Health System in Akron, Ohio has implemented a comprehensive suite of software solutions to streamline efficiency and control costs in its food outlets and gift shops.

8 Dec 2009

KFDA approves RPC's Onko-Sure in Vitro Diagnostic cancer test

US-based pharmaceutical company Radient Pharmaceuticals Corporation (RPC) announced today the Korean Food & Drug Administration (KFDA) has approved RPC's Onko-Sure™ in Vitro Diagnostic cancer test for routine clinical testing and government reimbursement throughout Korea.

4 Dec 2009

Despite declining smoking rates, U.S. obesity rates continue to rise

If obesity trends continue, the negative effect on the health of the U.S. population will overtake the benefits gained from declining smoking rates, according to a study by U-M and Harvard researchers published today in the New England Journal of Medicine.

3 Dec 2009

University HealthSystem Consortium signs agreement with ECRI Institute

The University HealthSystem Consortium (UHC) today announced that it has signed an agreement with ECRI Institute® in Plymouth Meeting, Pa, to offer its academic medical center members special pricing on ECRI's library of current technology research.

30 Nov 2009

Researchers predict diabetes cases to double and cost to triple in the next 25 years

The diabetes population in the United States will almost double over the next 25 years and annual medical spending on the disease is projected to hit $336 billion, up from $113 billion today, according to a study published in the December issue of Diabetes Care. The National Changing Diabetes® Program (NCDP), a program of Novo Nordisk, commissioned the analysis by a team from the University of Chicago.

27 Nov 2009

Climate change to have a profound impact on global public health

An emerging body of evidence suggests that the changing global climate is already affecting infectious disease transmission patterns. As noted today in a symposium at the 58th annual meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), such changes are expected to have a profound impact on global public health.

21 Nov 2009

Biotel reports net earnings of $128,000 for its first quarter ended September 30, 2009

Biotel Inc. announced results for its first quarter ended September 30, 2009 with net earnings of $128,000, or $0.04 per diluted share, on revenues of $3,263,000. This compares to net earnings of $328,000, or $0.11 per diluted share, on revenues of $3,168,000 for the first quarter of last year.

20 Nov 2009

Health care spending in Canada expected to reach $183.1 billion in 2009: CIHI

Health care spending in Canada is expected to reach $183.1 billion in 2009, an estimated increase of $9.5 billion, or 5.5%, since 2008, according to new figures released today by the Canadian Institute for Health Information (CIHI).

19 Nov 2009

Niusule Biotech announces financial guidance for year ending December 31, 2010

Niusule Biotech Corp., a leading U.S.-based biotech company focused on developing and selling nutritional products for children, today announced revenue, gross margin, and net income guidance for calendar year ending December 31, 2010 ("CY 2010").

19 Nov 2009

Planning and Forecasting system for healthcare organizations

CPM Marketing Group, Inc., the market leader for healthcare customer relationship management (CRM) and strategic marketing solutions, announced today the introduction of its Planning and Forecasting (P&F) system designed to provide actionable forecasting information to assist hospitals and health systems in planning.

18 Nov 2009

SCM Microsystems announces financial results for the third quarter of 2009

SCM Microsystems, Inc., a leading provider of solutions for secure access, secure identity and secure exchange, today announced results for its third quarter ended September 30, 2009. In the second reporting period following SCM's merger with Hirsch Electronics Corporation, revenue more than doubled, reflecting the success of the Company's strategy to increase its revenue by expanding its customer base and market reach through acquisitions and market investment.

16 Nov 2009

Presentation on how MedeAnalytics uses cloud computing

Yesterday, at the SPSS Directions 2009 North American Conference in Las Vegas, Nev., David Mould, Ph.D., predictive analytics scientist at MedeAnalytics, delivered a presentation to business executives, IT professionals, and researchers on ways MedeAnalytics uses cloud computing, also known as SaaS (Software-as-a-Service), to provide clients with advanced analytic tools and solutions.

11 Nov 2009

Understanding how regulatory networks drive development

Embryonic development is like a well-organised building project, with the embryo's DNA serving as the blueprint from which all construction details are derived. Cells carry out different functions according to a developmental plan, by expressing, i.e. turning on, different combinations of genes.

6 Nov 2009

Tea's healthy image keeps its market growing even in recession

If the recession has proven anything, it's that American consumers are willing to pay a premium for healthy products. Due to its compelling image as an innovative yet accessible beverage that is good tasting, good for you, and budget friendly, tea has remained profitable, with 2% annual gains in 2008 and 2009, according to "Tea and Ready-to-Drink (RTD) Tea in the U.S.: Retail, Foodservice and Consumer Trends," by leading market research publisher Packaged Facts.

6 Nov 2009

Medidata Solutions announces multi-year contract extension with Shire

Medidata Solutions, a leading global provider of hosted clinical development solutions, today announced a multi-year contract extension with Shire plc for use of Medidata Grants Manager™ and CRO Contractor™ benchmarking and analysis tools for investigator site and contract research organization (CRO) trial budget planning and forecasting.

4 Nov 2009

West Pharmaceutical Services reports financial results for the third quarter of 2009

West Pharmaceutical Services, Inc. today announced its results for the third quarter of 2009.

3 Nov 2009

Humana reports higher consolidated revenues for third quarter at $7.72 billion

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2009 (3Q09) of $1.78, consistent with management’s guidance of $1.75 to $1.80. The company earned $1.09 per share for the quarter ended September 30, 2008 (3Q08) which reflected $0.40 per share in realized losses primarily associated with other-than-temporary impairments in investments and sales of distressed financial institution securities.

2 Nov 2009